📊 Evidence-Based Reference

Cook Celect Platinum Vena Cava Filter Set for Femoral Approach Cook Celect Platium Vena Cava Filter Set for Jugular Appr

William Cook Europe ApS

Product: Cook Celect — all models and sizes

Contact a rep Compare similar devices

Summary: The Cook Celect Platinum Vena Cava Filter is a medical device used to prevent pulmonary embolism in patients who cannot undergo anticoagulation. Key evidence highlights its retrievability and management in complex cases.

FDA Clearance Information

Pathway ? 510(k)
Number ? K121629 ↗
Decision Date ? July 3, 2012
Product Code ? DTK Filter, Intravascular, Cardiovascular
Device Class ? Class 2
Evidence ? 11 studies

The Cook Celect Platinum Vena Cava Filter was cleared by the FDA via the 510(k) pathway on July 3, 2012. It is manufactured by William Cook Europe Aps and classified as a Class 2 device.

What It Is

The Cook Celect Platinum Vena Cava Filter is designed to be implanted in the inferior vena cava to prevent pulmonary embolism by capturing blood clots. It is intended for patients who have contraindications to anticoagulation therapy.

FDA-Cleared Indications

  • Prevention of pulmonary embolism by placement in the inferior vena cava.
  • Use in patients with a contraindication to anticoagulation therapy.
  • Use when pulmonary embolism may recur despite adequate anticoagulation therapy.

Clinical Applications

  • Percutaneous placement of a retrievable filter in the inferior vena cava.
  • Pulmonary embolism protection when anticoagulation is contraindicated.
  • Temporary protection during a period of elevated venous thromboembolism risk, when later retrieval is clinically appropriate.
  • Placement through a femoral or jugular venous approach using fluoroscopic imaging.

Reported off-label uses

  • Protection from pulmonary embolism in selected patients who cannot tolerate anticoagulation for reasons not specifically addressed in the device labeling.
  • Use in selected complex venous thromboembolism cases when clinicians judge that standard labeled options are insufficient.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes 7 studies ranging from 2018 to 2025, comprising retrospective reviews, case series, and prospective databases. These studies focus on retrieval outcomes, safety during anticoagulation, and mechanical properties.

Reported Outcomes

Published studies report effective retrieval outcomes with active patient management. The filter's mechanical properties support its use in preventing embolism, with studies highlighting successful retrieval even in complex cases.

Safety Profile

Reported complications include filter perforation, migration, and fracture, with varying incidence among different filter models. Safety during retrieval while on anticoagulation has been positively assessed.

Evidence Limitations

The evidence is limited by the retrospective nature of some studies and the small sample sizes in case series. Further research is needed to evaluate long-term outcomes and compare different filter models.

Practical Considerations

  • The set is available for femoral and jugular venous approaches; access-site anatomy and the intended deployment location should be confirmed before the procedure.
  • Placement is performed under fluoroscopic imaging, typically with local anesthetic and moderate sedation or another anesthesia plan based on the patient and procedure.
  • The filter is intended to be retrievable, but retrieval depends on clinical need, filter position, clot burden, endothelial incorporation and other anatomic factors.
  • MRI conditions should be confirmed from the current manufacturer labeling and implant documentation before scanning; MRI safety may depend on the specific filter configuration and field conditions.
  • Contraindications and precautions include conditions that make venous access, IVC placement or filter deployment unsafe, as well as factors that increase the risk of bleeding, infection, migration or thrombosis.

Procedures that use this device

Linked Studies (11)

PubMed • 2025

Two-Year Outcomes from the Cook Inferior Vena Cava Filter (CIVC) Study.

Journal of vascular and interventional radiology : JVIR

Prospective View Source →
PubMed • 2023

Management of failed inferior vena cava filter retrieval for complex cases: A case series.

Journal of clinical imaging science

View Source →
PubMed • 2022

Filter tilting and retrievability of the Celect and Denali inferior vena cava filters using propensity score-matching analysis.

European journal of radiology open

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Case report: Endoluminal removal of a retrievable conical inferior vena cava filter with a ruptured retraction hook attached to the wall.

Frontiers in surgery

Case Report View Source →
PubMed • 2018

Complications and retrieval characteristics of Celect Platinum inferior vena cava filters.

Journal of vascular surgery. Venous and lymphatic disorders

Retrospective View Source →
PubMed • 2016

Factors affecting Cook Gunther Tulip and Cook Celect inferior vena cava filter retrieval success.

Journal of vascular surgery. Venous and lymphatic disorders

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2009

Initial experience in 115 patients with the retrievable Cook Celect vena cava filter.

Journal of medical imaging and radiation oncology

Retrospective View Source →
PubMed • 2009

Deployment performance and retrievability of the Cook Celect vena cava filter.

Journal of vascular and interventional radiology : JVIR

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2005

New optional IVC filter for percutaneous retrieval--in vitro evaluation of embolus capturing efficiency.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

Celect Vena Cava Filter Clinical Trial

View Source →
ClinicalTrials.gov

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

View Source →

Frequently Asked Questions

What are the clinical indications for Cook Celect Platinum Vena Cava Filter?

The filter is indicated for patients at risk of pulmonary embolism who cannot undergo anticoagulation therapy.

What outcomes have been reported in clinical studies?

Studies report effective retrieval and management of complex cases, with successful outcomes in preventing embolism.

What complications have been reported?

Complications include filter perforation, migration, and fracture, with safety during retrieval being a key focus.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you